Role of Neurokinin 3 Receptor Signaling in Oral Squamous Cell Carcinoma
Authors:
- 23 October 2017
- journal article
- research article
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 37 (11) , 6119-6123
Abstract
Background/Aim: The neurokinin 3 receptor (NK-3R) is differentially expressed in the central nervous system including cases of human oral squamous cell carcinoma. However, the role of NK-3R signaling in oral squamous cell carcinoma is not well known. Materials and Methods: NK-3R expression in surgically resected oral squamous cell carcinoma was examined immunohistochemically and the strength of the expression was quantified. We evaluated the function of NK-3R signaling using NK-3R antagonist in human oral squamous cell carcinoma bone invasion mouse model. Results: NK-3R was significantly expressed in tumor cells that had invaded the bone matrix compared to the oral side tumor cells. SB222200, a selective antagonist of NK-3R, significantly suppressed the radiographic osteolytic lesion and tumorigenesis. Conclusion: NK-3R signaling is a potential target for the treatment of oral squamous cell carcinoma in cases of bone destruction.Keywords
This publication has 10 references indexed in Scilit:
- Age-related alterations in hypothalamic kisspeptin, neurokinin B, and dynorphin neurons and in pulsatile LH release in female and male ratsNeurobiology of Aging, 2017
- Tachykinin Receptor 3 Distribution in Human Oral Squamous Cell CarcinomaAnticancer Research, 2016
- Interactions Between Neurokinin B and Kisspeptin in Mediating Estrogen Feedback in Healthy WomenThe Journal of Clinical Endocrinology & Metabolism, 2016
- MicroRNA-125a Reduces Proliferation and Invasion of Oral Squamous Cell Carcinoma Cells by Targeting Estrogen-related Receptor αJournal of Biological Chemistry, 2014
- Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancerCancer Treatment Reviews, 2014
- Role of Neurokinin B in the Control of Female Puberty and Its Modulation by Metabolic StatusJournal of Neuroscience, 2012
- Neurokinin B activates the formation and bone resorption activity of rat osteoclastsNeuropeptides, 2011
- Antitumor Effect of Temsirolimus against Oral Squamous Cell Carcinoma Associated with Bone DestructionMolecular Cancer Therapeutics, 2010
- Bone metastasis is strongly associated with estrogen receptor–positive/progesterone receptor–negative breast carcinomasHuman Pathology, 2008
- Tachykinins and tachykinin receptors: a growing familyLife Sciences, 2004